Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03185403
Other study ID # 2012_47
Secondary ID 2013-002317-36
Status Completed
Phase N/A
First received May 30, 2017
Last updated June 12, 2017
Start date December 2013
Est. completion date January 2017

Study information

Verified date June 2017
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Continuous Paravertebral block (PVB) was reported to provide less episodes of hypotension than continuous thoracic epidural block (TEB). The maintenance of optimal tissue perfusion is essential for esophageal anastomosis in patients undergoing oesophagectomy. the aim of this study is to compare Hemodynamic effect of continous PVB compared to TEB , in patient undergoing oesophagectomy with laparoscopy and thoracotomy.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date January 2017
Est. primary completion date July 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- ASA score 1 to 3

- oesophagectomy : abdominal time with laparoscopy ans thoracic time with thoracotomy

Exclusion Criteria:

- pregnancy

- Uncooperative patient

- patient refusal

- Coagulopathy

- allergy to local anesthetic

- Psychological Disorders

- Failure to install the epidural or paravertebral catheter. The patient will therefore be excluded secondarily but will be able to benefit from an alternative technique for the management of his pain.

- Sepsis

- Skin infection at the puncture site

- Allergy to local anesthetics

- Esophagectomy with cervical surgical time

- Patient with chronic pain EVA> 4 before surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
paravertebral block
in the paravertebral block , the catheter was placed under ultrasound echography , at the right thoracic T4/T5 level
thoracic epidural block
in the epidural block the catheter was inserted without echography , at T4/T5 level
Drug:
ropivacaine

Sufentanil


Locations

Country Name City State
France CHRU , Hôpital Claude Huriez Lille

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

References & Publications (1)

Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2006 Apr;96(4):418-26. Epub 2006 Feb 13. Review. Erratum in: Br J Anaesth. 2007 Nov;99(5):768. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of hypotension episodes The frequency of hypotension episodes defined by a mean arterial pressure (MAP) less than 70mmHg or a decrease in MAP greater than 20% when compared with the preoperative value during perioperative until first 24 hours post operative
Secondary Total amount per patient and per group of vasopressins amines during perioperative until first 24 hours post operative
Secondary Frequency of use of vasopressor agents during perioperative until first 24 hours post operative
Secondary Volumes of fluid administered during perioperative until the first 24h hours post operative
Secondary total amount of morphine consumption during first 48 hours post operative
Secondary visual analog scale Measure the pain severity during first 48 hours post operative, at 3 months and 6 months
Secondary DN2 score evaluation with validated scores for chronic and neuropathic pains during first 48 hours post operative, at 3 months and 6 months
Secondary Frequency of surgical complications during first 48 hours post operative
Secondary Frequency of pulmonary complications during first 48 hours post operative
Secondary total amount and frequency of Post-operative anti-emetic consumption during first 48 hours post operative
Secondary Death up to 28 days postoperative
See also
  Status Clinical Trial Phase
Recruiting NCT05685862 - Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit
Recruiting NCT01795768 - Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours Phase 2
Completed NCT05266300 - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Recruiting NCT03978377 - Cardiopulmonary Toxicity of Thoracic Radiotherapy
Active, not recruiting NCT03653052 - Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab Phase 2
Recruiting NCT05489250 - The PLATON Network
Recruiting NCT04484636 - PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) N/A
Terminated NCT01795976 - NY-ESO-1 T Cells in OG Cancer Phase 2
Recruiting NCT01843829 - A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer Phase 2
Completed NCT01915693 - ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study Phase 3
Completed NCT02382237 - Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition N/A
Recruiting NCT04517448 - Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
Recruiting NCT04232735 - Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) N/A
Recruiting NCT05642819 - REVOLUTION Surgery (REVOLUTION Surgery)
Recruiting NCT04001478 - Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
Recruiting NCT02741856 - Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation Phase 2/Phase 3
Not yet recruiting NCT05600608 - Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome N/A
Recruiting NCT04481256 - TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY N/A
Recruiting NCT05057013 - HMBD-001 in Advanced HER3 Positive Solid Tumours Phase 1/Phase 2
Not yet recruiting NCT06046846 - Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer N/A